Basic Information
ID: ALA2174315
Type: Functional
Description: Antagonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as inhibition of human 26RFa-induced increase in intracellular calcium level by fluorimetry
Format: BAO_0000219
Organism: Homo sapiens
Cell type: CHO
Target: Pyroglutamylated RFamide peptide receptor(ALA5852)
Document: ALA2169738
Antagonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as inhibition of human 26RFa-induced increase in intracellular calcium level by fluorimetry: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA2174315
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 2832.18 | ||
| 815.93 | -3.05 | -3.05 |
| 830.95 | -3.54 | -3.54 |
| 830.95 | -3.54 | -3.54 |
| 830.95 | -3.24 | -3.24 |
| 844.97 | -3.20 | -3.20 |
| 830.95 | -3.24 | -3.24 |
| 830.95 | -3.59 | -3.59 |
| 830.95 | -3.24 | -3.24 |
| 875.00 | -3.84 | -3.84 |
| 814.95 | -2.56 | -2.56 |
| 843.00 | -1.78 | -1.78 |
| 857.03 | -1.39 | -1.39 |
| 897.09 | -0.61 | -0.61 |